BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P
51 results:

  • 1. Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the eps15/EGFR complex.
    Gu L; Jin X; Liang H; Yang C; Zhang Y
    Pharmacol Res; 2023 Jun; 192():106789. PubMed ID: 37149115
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evidence on percutaneous radiofrequency and microwave ablation for liver metastases over the last decade.
    Tomita K; Matsui Y; Uka M; Umakoshi N; Kawabata T; Munetomo K; Nagata S; Iguchi T; Hiraki T
    Jpn J Radiol; 2022 Oct; 40(10):1035-1045. PubMed ID: 36097234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study.
    Rumgay H; Shield K; Charvat H; Ferrari P; Sornpaisarn B; Obot I; Islami F; Lemmens VEPP; Rehm J; Soerjomataram I
    Lancet Oncol; 2021 Aug; 22(8):1071-1080. PubMed ID: 34270924
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
    Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
    Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effects of In-Hospital Physical Therapy on Activities of Daily Living in Patients with Hepatocellular Carcinoma.
    Narao H; Hirota K; Koya S; Tomita M; Manako Y; Ogawa S; Nakao N; Tsutsumi T; Nakano D; Hashida R; Kawaguchi T; Matsuse H; Nagamatu H; Torimura T
    Int J Environ Res Public Health; 2020 Dec; 17(23):. PubMed ID: 33291223
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Funding of Hispanic/Latino Health-Related Research by the National Institutes of Health: An Analysis of the Portfolio of Research Program Grants on Six Health Topic Areas.
    Avilés-Santa ML; Hsu L; Lam TK; Arteaga SS; Artiles L; Coady S; Cooper LS; Curry J; Desvigne-Nickens P; Nicastro HL; Rosario A
    Front Public Health; 2020; 8():330. PubMed ID: 33014952
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Conservation and variability of hepatitis B core at different chronic hepatitis stages.
    Yll M; Cortese MF; Guerrero-Murillo M; Orriols G; Gregori J; Casillas R; González C; Sopena S; Godoy C; Vila M; Tabernero D; Quer J; Rando A; Lopez-Martinez R; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
    World J Gastroenterol; 2020 May; 26(20):2584-2598. PubMed ID: 32523313
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mean corpuscular hemoglobin concentration correlates with prognosis of resected hepatocellular carcinoma.
    Kong W; Zheng J; Chen L; Zuo X; Wang H; Wang X; Yao J; Chen W
    Biomark Med; 2020 Mar; 14(4):259-270. PubMed ID: 32134324
    [No Abstract]    [Full Text] [Related]  

  • 9. Current cancer Epidemiology.
    Mattiuzzi C; Lippi G
    J Epidemiol Glob Health; 2019 Dec; 9(4):217-222. PubMed ID: 31854162
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
    Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Blocking Endogenous H
    Zhang H; Song Y; Zhou C; Bai Y; Yuan D; Pan Y; Shao C
    Radiat Res; 2018 Oct; 190(4):374-384. PubMed ID: 30016218
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
    Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
    J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.
    Lu M; Wu J; Hao ZW; Shang YK; Xu J; Nan G; Li X; Chen ZN; Bian H
    Hepatology; 2018 Jul; 68(1):317-332. PubMed ID: 29356040
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells.
    Madsen SD; Russell KC; Tucker HA; Glowacki J; Bunnell BA; O'Connor KC
    Stem Cell Res Ther; 2017 Sep; 8(1):201. PubMed ID: 28962588
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Liu J; Ni W; Qu L; Cui X; Lin Z; Liu Q; Zhou H; Ni R
    Dig Dis Sci; 2016 Sep; 61(9):2554-67. PubMed ID: 27221498
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Development of a web-based liver cancer prediction model for type II diabetes patients by using an artificial neural network.
    Rau HH; Hsu CY; Lin YA; Atique S; Fuad A; Wei LM; Hsu MH
    Comput Methods Programs Biomed; 2016 Mar; 125():58-65. PubMed ID: 26701199
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. AN INITIAL INDICATION OF PREDISPOSING RISK OF SCHISTOSOMA MANSONI INFECTION FOR HEPATOCELLULAR CARCINOMA.
    Sabry Ael H; El-Aal AA; Mahmoud NS; Nabil Y; Aziz IZ
    J Egypt Soc Parasitol; 2015 Aug; 45(2):233-40. PubMed ID: 26485842
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
    Song HJ; Cheng JY; Hu SL; Zhang GY; Fu Y; Zhang YJ
    Clin Radiol; 2015 Feb; 70(2):128-37. PubMed ID: 25459673
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Regioselective synthesis of polycyclic aza-oxa and aza-oxa-thia heteroarenes as Colo-205 and HepG2 carcinoma cells growth inhibitors.
    Maurya HK; Gautam SK; Pratap R; Tandon VK; Kumar A; Kumar B; Saxena S; Tripathi D; Rajwanshi M; Das M; Ram VJ
    Eur J Med Chem; 2014 Jun; 81():367-77. PubMed ID: 24858542
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. liver transplantation for intra- and extrahepatic cholangiocarcinoma.
    Schmeding M; Neumann UP
    Ann Transplant; 2013 Jan; 18():1-8. PubMed ID: 23792495
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.